Lenalidomide therapy in a patient with POEMS syndrome

被引:77
作者
Dispenzieri, Angela [1 ]
Klein, Christopher J. [1 ]
Mauermann, Michelle L. [1 ]
机构
[1] Mayo Clin, Rochester, MN 55905 USA
关键词
D O I
10.1182/blood-2007-03-082354
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页码:1075 / 1076
页数:2
相关论文
共 10 条
[1]   Bevacizumab therapy for POEMS syndrome [J].
Badros, A ;
Porter, N ;
Zimrin, A .
BLOOD, 2005, 106 (03) :1135-1135
[2]   Peripheral blood stem cell transplantation in 16 patients with POEMS syndrome: and a review of the literature [J].
Dispenzieri, A ;
Moreno-Aspitia, A ;
Suarez, GA ;
Lacy, MQ ;
Colon-Otero, G ;
Tefferi, A ;
Litzow, MR ;
Roy, V ;
Hogan, WJ ;
Kyle, RA ;
Gertz, MA .
BLOOD, 2004, 104 (10) :3400-3407
[3]   Overproduction of proinflammatory cytokines imbalanced by their antagonists in POEMS syndrome [J].
Gherardi, RK ;
Belec, L ;
Soubrier, M ;
Malapert, D ;
Zuber, M ;
Viard, JP ;
Intrator, L ;
Degos, JD ;
Authier, FJ .
BLOOD, 1996, 87 (04) :1458-1465
[4]   Thalidomide for POEMS syndrome [J].
Kim, So Yeon ;
Lee, Sun Ah ;
Ryoo, Hun Mo ;
Lee, Kyung Hee ;
Hyun, Myung Soo ;
Bae, Sung Hwa .
ANNALS OF HEMATOLOGY, 2006, 85 (08) :545-546
[5]   Combination therapy with lenalidomide plus dexamethasone (Rev/Dex) for newly diagnosed myeloma [J].
Rajkumar, SV ;
Hayman, SR ;
Lacy, MQ ;
Dispenzieri, A ;
Geyer, SM ;
Kabat, B ;
Zeldenrust, SR ;
Kumar, S ;
Greipp, PR ;
Fonseca, R ;
Lust, JA ;
Russell, SJ ;
Kyle, RA ;
Witzig, TE ;
Gertz, MA .
BLOOD, 2005, 106 (13) :4050-4053
[6]   Immunomodulatory drug CC-5013 overcomes drug resistance and is well tolerated in patients with relapsed multiple myeloma [J].
Richardson, PG ;
Schlossman, RL ;
Weller, E ;
Hideshima, T ;
Mitsiades, C ;
Davies, F ;
LeBlanc, R ;
Catley, LP ;
Doss, D ;
Kelly, K ;
McKenney, M ;
Mechlowicz, J ;
Freeman, A ;
Deocampo, R ;
Rich, R ;
Ryoo, JJ ;
Chauhan, D ;
Balinski, K ;
Zeldis, J ;
Anderson, KC .
BLOOD, 2002, 100 (09) :3063-3067
[7]   Bevacizumab therapy for POEMS syndrome [J].
Straume, O ;
Bergheim, J ;
Ernst, P .
BLOOD, 2006, 107 (12) :4972-4973
[8]   Neurological toxicity of long-term (>1 yr) thalidomide therapy in patients with multiple myeloma [J].
Tosi, P ;
Zamagni, E ;
Cellini, C ;
Plasmati, R ;
Cangini, D ;
Tacchetti, P ;
Perrone, G ;
Pastorelli, F ;
Tura, S ;
Baccarani, M ;
Cavo, M .
EUROPEAN JOURNAL OF HAEMATOLOGY, 2005, 74 (03) :212-216
[9]  
Watanabe O, 1998, MUSCLE NERVE, V21, P1390, DOI 10.1002/(SICI)1097-4598(199811)21:11<1390::AID-MUS5>3.3.CO
[10]  
2-S